ANTI-OBESITY MEDICATIONS

Off-label Drugs for Weight Management

For over 2 decades, Dr. Hendricks has consistently dedicated his time to staying current with new research findings.  Because of his research activities, with the help of our patients, he is widely regarded as an expert in his field by Bariatric Medicine specialists across the globe. On June 13, 2017, the Dovepress published, worldwide, Dr. [...]

Learn how our patient reversed her diabetes.

If you want to learn more about how YOU can reverse or manage YOUR diabetes, set up a complimentary consultation today. In June 2016, Dr. Hendricks and our patient Piper co-authored a published article discussing how Hendricks for Health helped her reverse diabetes and taught her how to live a healthier lifestyle. Read Pharmacotherapy for Obesity and [...]

Addiction potential of phentermine prescribed for obesity

Objective: To determine whether long-term phentermine treatment produces any sign or symptom of abuse or addiction. Date of Research Idea: October 2007. Collaborators: Frank L. Greenway, M.D., Pennington Biomedical Research Center, Louisiana State University. Manit Srisurapanont, M.D., Ph.D., Chaig Mai University, Chang Mai, Thailand, Stacy Schmidt, University of Colorado Anschutz Medical Center, Denver. Description: A [...]

Blood Pressure, Heart rate effects, Weight Loss, and Maintenance During Long-term Phentermine Treatment for Obesity.

Objective: To determine cardiovascular safety and effectiveness of long-term phentermine treatment. Date of Research Idea: October 2009. Collaborators: Eric C. Westman, M.D., Duke University, Frank L. Greenway, M.D., Pennington Biomedical Research Center, Louisiana State University. Alok K. Gupta, M.D., Pennington Biomedical Research Center Description: A retrospective observational study of 300 sequential returning patients treated with [...]

Does abrupt cessation of phentermine treatment for obesity induce amphetamine-like withdrawal?

Objective: To determine if patients taking prescribed phentermine long-term who quit taking the drug develop any signs of an amphetamine-like withdrawal syndrome. Date of Research Idea: December 2007. Collaborator: Frank L. Greenway, M.D., Pennington Biomedical Research Center, Louisiana State University. Description: A retrospective observational study of patients who had chosen to cease taking phentermine. The [...]

Survey of U.S. Obesity treatment specialists prescribing practices

Objective: To determine how obesity treatment specialists use pharmacotherapy for treating obesity. To determine what drugs are being used in what doses and for what durations. Date of Research Idea: October 2007. Collaborators: Frank L. Greenway, M.D., Pennington Biomedical Research Center, Louisiana State University; Richard B. Rothman, M.D., Ph.D., National Institute of Drug Abuse. Description: [...]

BACKGROUND ON Our Clinical Research

The concept of using a medicine to treat obesity began a hundred years ago and some of the compounds tried before World War II had some truly awful side effects so it was inevitable that controversy arose when the newly created FDA approved an amphetamine for treating obesity in 1944. At the time the American [...]

Dr. Hendricks Appointed to FDA Drug Advisory Panel

The U.S. Food and Drug Administration has appointed Ed J. Hendricks, M.D., a Sacramento-area obesity treatment specialist, to the FDA Endocrinologic and Metabolic Drug Advisory Committee (EMDAC). The EMDAC is the FDA-selected panel of experts that reviews new drugs for treating obesity, advising the FDA if these drugs should be approved. Dr. Hendricks, who has [...]